News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Danahy Kevin Patrick
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/14/2023 |
4
| Danahy Kevin Patrick (CEO) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 200,000 options to buy
@ $7.08, valued at
$1.4M
|
|
| 05/02/2023 |
4
| Danahy Kevin Patrick (CEO) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 500,000 options to buy
@ $6.44, valued at
$3.2M
|
|
| 03/24/2023 |
4
| Danahy Kevin Patrick (CEO) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 25,000 options to buy
@ $6.41, valued at
$160.3k
|
|
| 10/03/2022 |
4
| Danahy Kevin Patrick (CEO) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Bought 6,500 shares
@ $2.3, valued at
$15k
|
|
| 09/27/2022 |
4
| Danahy Kevin Patrick (CEO) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 450,000 options to buy
@ $1.53, valued at
$688.5k
|
|
| 03/22/2022 |
4
| Danahy Kevin Patrick (Chief Commercial Office) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 300,000 options to buy
@ $6.41, valued at
$1.9M
|
|
| 03/22/2022 |
3
| Danahy Kevin Patrick (Chief Commercial Officer) has filed a Form 3 on Pulse Biosciences, Inc. |
|
|